Aspiration Therapy for the Treatment of Obesity: Four Year Results of a Multicenter Randomized Controlled Trial

The AspireAssist is the first FDA-approved endoluminal device indicated for treatment of Class II and III obesity. We earlier reported one-year results of the PATHWAY study. Here, we report 4 year outcomes.

Source: Surgery for Obesity and Related Diseases - May 1, 2019 Category: Surgery Authors: Christopher C. Thompson, Barham K. Abu Dayyeh, Vladimir Kushnir, Robert F. Kushner, Pichamol Jirapinyo, Alan B. Schorr, Louis J. Aronne, Anastassia Amaro, David L. Jaffe, Allison R. Schulman, Dayna Early, Adam C. Stein, Reem Sharaiha, Steven Edmundowicz, Tags: Original articles Source Type: research